The World Health Organization (WHO), in partnership with the Global Fund and Stop TB Partnership, has launched the initiative “Find. Treat. All. #EndTB." The campaign site includes more information about the initiative, social media tiles, and other TB-related links.
This compendium report provides a detailed review of monitoring and evaluation (M&E) for national TB programs and indicators for measuring DOTS implementation and expansion. The review includes information on M&E for TB control programs, sources of data, and effective use of M&E data for program improvement and advocacy.
This manual outlines a global strategy for the development and strengthening of TB laboratory networks. The strategy recognizes the need to upgrade existing laboratory services and to strengthen/build capacity to perform culture and drug susceptibility testing (DST) in areas experiencing a high burden of acid-fast bacilli (AFB) smear-negative TB associated with human immunodeficiency virus (HIV) infection and to support DOTS-Plus projects.
This document is intended to raise awareness about TB/HIV research priorities (i.e. areas that require urgent funding and scientific interest), help coordinate advocacy efforts, and encourage research funding. The aim is to increase the implementation of high-quality, integrated TB/HIV interventions in resource-limited settings. The document outlines a revised research priority agenda based on the latest evidence in six key areas of TB and HIV co-infection.
This is the eighteenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and ?nancing TB prevention, care and control at global, regional and country levels using data reported by 197 countries and territories that account for over 99% of the world’s TB cases.
The primary purposes of this framework are to: 1) promote, enhance, and intensify TB research and innovation at the country level, and 2) promote, enhance, and catalyze TB research at the global level through advocacy, innovation, discussion of global priorities, and the development of networks for research and capacity building.
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.
This book provides a basis for the diagnosis and management of tuberculosis. It is presented in a question-and-answer format, with subject matter grouped under the three headings: Case Detection, Treatment, and Monitoring.
These guidelines for laboratory services are contained in a series of three manuals, two of which are focused on the technical aspects of tuberculosis microscopy and culture and a third which deals with laboratory management, including aspects such as laboratory safety and proficiency testing. These manuals have been developed for use in low-and middle-income countries with high tuberculosis prevalence and incidence rates. Not only are they targeted to everyday laboratory use, but also for incorporation in teaching and training of laboratory and other health care staff.
This document addresses a broad range of ethical issues arising in TB programmes, ranging from informed consent and isolation to health-care workers' rights and obligations, and clinical and epidemiological studies.
